Q2 2025 Holdings
Filed 2025-08-15 | 15 holdings | $8.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biontech SE(BNTX) | COM | 09075V102 | $7.8M | 73,382 | 97.7% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $29.1K | 101,146 | 0.4% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $22.5K | 133,745 | 0.3% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $21.8K | 493,526 | 0.3% |
| Jazz Pharmaceuticals PLC(JAZZ) | COM | G50871105 | $17.5K | 164,816 | 0.2% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $16.0K | 2,114,444 | 0.2% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $14.9K | 472,376 | 0.2% |
| Indivior PLC(INDV) | COM | G4766E116 | $14.4K | 974,474 | 0.2% |
| GSK PLC(GSK) | COM | 37733W204 | $10.4K | 271,729 | 0.1% |
| Avadel Pharmaceuticals | COM | G29687103 | $8.5K | 958,877 | 0.1% |
| Sanofi(SNY) | COM | 80105N105 | $7.2K | 148,946 | 0.1% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $6.1K | 40,000 | 0.1% |
| Alkermes PLC(ALKS) | COM | G01767105 | $5.9K | 207,822 | 0.1% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $4.8K | 1,024,883 | 0.1% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $2.1K | 4,000 | 0.0% |